Strumento inattivo

Altre lingue First Light Acquisition Group, Inc. Nyse

Azioni

FLAG.U

US3207032000

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Calidi Biotherapeutics Announces Upcoming Presentations at the 2024 ASCO Annual Meeting	01/05
Join Calidi Biotherapeutics Exclusive Live Investor Webinar and Q&A Session on April 24	24/04
Join Calidi Biotherapeutics’ Exclusive Live Investor Webinar and Q&A Session on April 24	23/04
Calidi Biotherapeutics, Inc. Announces Closing of $6.1 Million Public Offering	19/04
Calidi Biotherapeutics Prices $6.1 Million Offering	16/04
Calidi Biotherapeutics, Inc. Announces Pricing of $6.1 Million Public Offering	16/04
Calidi Biotherapeutics Presents New Data on the Mechanisms of Action for Virotherapy-Loaded Stem Cells Used in the Company's Novel Immunotherapies at the AACR Annual Meeting 2024	10/04
Calidi Biotherapeutics Presents New Data on the Mechanisms of Action for Virotherapy-Loaded Stem Cells Used in the Company’s Novel Immunotherapies at the AACR Annual Meeting 2024	09/04
Calidi Biotherapeutics, Inc. announced that it has received $3.5 million in funding	21/03
Calidi Biotherapeutics Reports Fourth Quarter and Full-Year 2023 Operating and Financial Results	15/03
Calidi Biotherapeutics and City of Hope Announce Funding from the California Institute for Regenerative Medicine (CIRM) to Advance CLD-101 (NeuroNova) in Ovarian Cancer	11/03
Calidi Biotherapeutics, Inc. announced that it expects to receive $3.5 million in funding	08/03
Calidi Biotherapeutics to Highlight Novel Systemic Enveloped Oncolytic Virotherapy Platform Designed to Target All Tumor Sites at Upcoming Conference	12/02
Sector Update: Health Care Stocks Firmer Late Afternoon	07/02
Calidi Biotherapeutics to Sell Common Stock	07/02
Calidi Biotherapeutics, Inc. announced that it has received $1 million in funding	26/01
Calidi Biotherapeutics Announces the Appointment of Three New Members to its Scientific and Medical Advisory Board	08/01
Calidi Biotherapeutics, Inc. Announces Scientific and Medical Advisory Board Appointments	08/01
Calidi Biotherapeutics, Inc.(NYSEAM:CLDI) added to S&P TMI Index	18/12
Calidi Biotherapeutics Announces Appointment of Pharmaceutical Industry Veteran David LaPre to its Board of Directors	13/12

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue First Light Acquisition Group, Inc. Nyse

Azioni

FLAG.U

US3207032000

Altre lingue

Filtri